PMID- 23001982 OWN - NLM STAT- MEDLINE DCOM- 20130422 LR - 20211021 IS - 1098-2825 (Electronic) IS - 0887-8013 (Print) IS - 0887-8013 (Linking) VI - 26 IP - 5 DP - 2012 Sep TI - Alterations of dendritic cell subsets and TH1/TH2 cytokines in the peripheral circulation of patients with superficial transitional cell carcinoma of the bladder. PG - 365-71 LID - 10.1002/jcla.21532 [doi] AB - BACKGROUND: Dendritic cells (DCs) and cytokines play an important role in the tumor growth and recurrence. METHODS: Sixty-six patients with superficial transitional cell carcinoma of the bladder (STCCB) and 38 healthy controls were studied to investigate the percentages of DC subsets, monocyte-derived DC (MoDC) function, and alterations of Th1 and Th2 cytokines. MoDCs were generated and three-color flow cytometry was used for determining the phenotype of MoDCs and DC subsets. The ability to stimulate autologous T cells was tested in mixed leukocyte reaction (MLR). The levels of various cytokines were measured using commercially available sandwich enzyme linked immunosorbent assay (ELISA) kit. RESULTS: The myeloid DC (mDC) counts, MoDC surface molecular expression, and stimulatory capacity to T cells were impaired in STCCB patients than in controls. The percentage of mDC and the expression of CD80, CD83, and CD86 were lower in patients showing recurrence. The serum levels of IL-2 and IFN-gamma were found to be significantly lower while IL-4, IL-6, and IL-10 were significantly higher in STCCB patients than in controls. IL-6 was found to be significantly higher in recurrent patients. CONCLUSION: The impairment of mDC counts and MoDC function with imbalance of Th1/Th2 cytokines was closely associated with proliferation and recurrence of STCCB. CI - (c) 2012 Wiley Periodicals, Inc. FAU - Lang, Feng AU - Lang F AD - Department of Urology, Beijing Friendship Hospital, Capital Medical University, Beijing, China. FAU - Linlin, Ma AU - Linlin M FAU - Ye, Tian AU - Ye T FAU - Yuhai, Zhang AU - Yuhai Z LA - eng PT - Journal Article PL - United States TA - J Clin Lab Anal JT - Journal of clinical laboratory analysis JID - 8801384 RN - 0 (Cytokines) SB - IM MH - Adult MH - Aged MH - Analysis of Variance MH - Carcinoma, Transitional Cell/*blood/immunology MH - Case-Control Studies MH - Cytokines/*blood/immunology MH - Dendritic Cells/*immunology/pathology MH - Female MH - Humans MH - Male MH - Middle Aged MH - Neoplasm Recurrence, Local/blood/immunology MH - Phenotype MH - Th1 Cells/immunology/pathology MH - Th2 Cells/immunology/pathology MH - Urinary Bladder Neoplasms/*blood/immunology PMC - PMC6807352 EDAT- 2012/09/25 06:00 MHDA- 2013/04/23 06:00 PMCR- 2012/09/21 CRDT- 2012/09/25 06:00 PHST- 2012/09/25 06:00 [entrez] PHST- 2012/09/25 06:00 [pubmed] PHST- 2013/04/23 06:00 [medline] PHST- 2012/09/21 00:00 [pmc-release] AID - JCLA21532 [pii] AID - 10.1002/jcla.21532 [doi] PST - ppublish SO - J Clin Lab Anal. 2012 Sep;26(5):365-71. doi: 10.1002/jcla.21532.